CalciMedica Inc. (NASDAQ: CALC)
$2.7700
+0.0100 ( 0% ) 4.2K
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Market Data
Open
$2.7700
Previous close
$2.7600
Volume
4.2K
Market cap
$37.88M
Day range
$2.7620 - $2.8200
52 week range
$2.0500 - $8.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | May 13, 2024 |
10-q | Quarterly Reports | 59 | May 13, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |